AHP REDUX FINAL LABELING IS "FAVORABLE," COMPANY TELLS ANALYSTS; PREMPRO/PREMPHASE COMBO TAB GAINS 13% MARKET SHARE IN TWO MONTHS
Executive Summary
American Home Products believes that it will have "favorable" labeling for the anti-obesity agent Redux (dexfenfluramine), the company told securities analysts during a March 28 R&D presentation at its Pearl River, N.Y. research facility.